Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Bevacizumab used for the treatment of severe, refractory perilesional edema due to an arteriovenous malformation treated with stereotactic radiosurgery.
C3aR inhibition reduces neurodegeneration in experimental lupus.
Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
The Ethics of Introducing New Surgical Technology Into Clinical Practice: The Importance of the Patient-Surgeon Relationship.
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes. N Engl J Med. 2016 11 24; 375(21):2023-2036.
View in:
PubMed
subject areas
5-Methylcytosine
Adult
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic
Azacitidine
Biomarkers, Tumor
Bone Marrow
Exome
Female
Humans
Leukemia, Myeloid, Acute
Male
Middle Aged
Mutation
Myelodysplastic Syndromes
Prospective Studies
Risk Factors
Survival Rate
Tumor Suppressor Protein p53
authors with profiles
Wendy Stock